Mr. Charles Edgar Averill Jr., O.T.R. L. Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 704a South Missouri, Macon, MO 63552 Phone: 660-385-2500 |
Janet C Ancell, OTR Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1706 Prospect Dr, Suite B, Macon, MO 63552 Phone: 660-385-6540 Fax: 660-385-6542 |
Mrs. Kirsten Renae Simms, OTRL Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 29612 Kellogg Ave, Macon, MO 63552 Phone: 573-886-0209 |
News Archive
Clinical trials using patients' own immune cells to target tumors have yielded promising results. However, this approach usually works only if the patients also receive large doses of drugs designed to help immune cells multiply rapidly, and those drugs have life-threatening side effects. Now a team of MIT engineers has devised a way to deliver the necessary drugs by smuggling them on the backs of the cells sent in to fight the tumor. That way, the drugs reach only their intended targets, greatly reducing the risk to the patient.
Even after emergency physicians had acclimated to a new commercial electronic health record (EHR), they increased their tasks performed per minute by nearly 12 percent, increasing the potential for patient safety hazards.
ContextVision, the software imaging partner for the most recognized medical imaging manufacturers worldwide, today is pleased to announce that it has entered into a strategic collaboration with Neusoft Medical Systems Co., Ltd (Neusoft Medical, hereafter "NMS"), a leading provider of a broad range of medical equipment & IT solutions and healthcare services in China. NMS is a wholly-owned subsidiary of Neusoft Corporation, which is a leading IT solutions and services provider in China with revenue in excess of $600 million in 2009.
The common approach of intensive glucose control to achieve low blood sugar targets in type 2 diabetes can increase the risk of mortality, finds a study by Cardiff University.
Mosquitoes that carry malaria are increasingly becoming resistant to pyrethroid insecticides, which are the only insecticides approved by the WHO to treat bed nets and are the most effective and cost efficient for indoor spraying, Nature News reports.
› Verified 7 days ago